Karan Govindpani
Auckland, AUK 1023, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impaired Expression of GABA Signaling Components in the Alzheimer's Disease Middle Temporal Gyrus.
Journal: International journal of molecular sciences
Published: October 30, 2020
An 5 GABAA Receptor Inverse Agonist, 5IA, Attenuates Amyloid Beta-Induced Neuronal Death in Mouse Hippocampal Cultures.
Journal: International journal of molecular sciences
Published: April 07, 2020
Vascular dysfunction in Alzheimer's disease: a biomarker of disease progression and a potential therapeutic target.
Journal: Neural regeneration research
Published: December 12, 2019
Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probes.
Journal: Bioorganic & medicinal chemistry letters
Published: June 07, 2019
Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It?
Journal: Journal of clinical medicine
Published: March 31, 2019
Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway.
Journal: Neural regeneration research
Published: August 15, 2018
The GABAergic system as a therapeutic target for Alzheimer's disease.
Journal: Journal of neurochemistry
Published: October 18, 2017
Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: July 31, 2017
One for the Price of Two…Are Bivalent Ligands Targeting Cannabinoid Receptor Dimers Capable of Simultaneously Binding to both Receptors?
Journal: Trends in pharmacological sciences
Published: November 26, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026